| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Lake City Medical Center is a Lake City, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PatientPoint powers more effective patient-physician engagements across all points of care. With 30 years of unrivaled experience and continual, meaningful innovation, we are trusted consultants to healthcare providers and sponsoring brands. Using superior analytics and insights, we craft customized programs that drive better engagements. From primary care to complex specialties, from practices to hospitals, PatientPoint provides a cohesive, end-to-end communication platform that enriches the entire care experience and delivers proven results.
Kaléo is dedicated to inventing, manufacturing and commercializing life-transforming products that empower patients and families to live fuller, bolder lives. We are committed to developing solutions that support the healthcare provider-patient relationship, improving access to our products.